Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Zbar

Showing results (91-100 of 263) with videos related to

Pageof 27
Sort By:
Proteins|May 17, 2001
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studiesM Miller, K Ginalski, B Lesyng, et al.
Journal of the National Cancer Institute|March 1, 1970
Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophilsB Zbar, H T Wepsic, H J Rapp, et al.
The Histochemical Journal|July 23, 1999
Expression of von Hippel-Lindau protein in normal and pathological human tissuesN Sakashita, M Takeya, T Kishida, et al.
Important Advances in Oncology|January 1, 1993
Genetic basis of renal cell cancerW M Linehan, J R Gnarra, M I Lerman, et al.
Human Molecular Genetics|October 1, 1993
TaqI and PstI RFLPs in the von Hippel-Lindau disease gene (VHL)F M Richards, F Latif, M I Lerman, et al.
Cancer Research|November 1, 1981
Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigensB Zbar, V Manohar, T Sugimoto, et al.
Journal of Medical Genetics|August 1, 1996
Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2AF Chen, L Slife, T Kishida, et al.
Journal of the National Cancer Institute|January 1, 1971
Abrogation of passively transferred tumor immunity in vivo by antigenically related tumor cellsH T Wepsic, I D Bernstein, B Zbar, et al.
Journal of the National Cancer Institute|August 1, 1970
Immunotherapy of an intramuscular tumor in strain-2 guinea pigs: prevention of tumor growth by intradermal immunization and by systemic transfer of tumor immunityH T Wepsic, B S Kronman, B Zbar, et al.
The Journal of Urology|December 1, 1995
Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implicationsM M Walther, I A Lubensky, D Venzon, et al.
Pageof 27

Showing results (91-100 of 263) with videos related to

Sort By:
Pageof 27
Proteins|May 17, 2001
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studiesM Miller, K Ginalski, B Lesyng, et al.
Journal of the National Cancer Institute|March 1, 1970
Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophilsB Zbar, H T Wepsic, H J Rapp, et al.
The Histochemical Journal|July 23, 1999
Expression of von Hippel-Lindau protein in normal and pathological human tissuesN Sakashita, M Takeya, T Kishida, et al.
Important Advances in Oncology|January 1, 1993
Genetic basis of renal cell cancerW M Linehan, J R Gnarra, M I Lerman, et al.
Human Molecular Genetics|October 1, 1993
TaqI and PstI RFLPs in the von Hippel-Lindau disease gene (VHL)F M Richards, F Latif, M I Lerman, et al.
Cancer Research|November 1, 1981
Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigensB Zbar, V Manohar, T Sugimoto, et al.
Journal of Medical Genetics|August 1, 1996
Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2AF Chen, L Slife, T Kishida, et al.
Journal of the National Cancer Institute|January 1, 1971
Abrogation of passively transferred tumor immunity in vivo by antigenically related tumor cellsH T Wepsic, I D Bernstein, B Zbar, et al.
Journal of the National Cancer Institute|August 1, 1970
Immunotherapy of an intramuscular tumor in strain-2 guinea pigs: prevention of tumor growth by intradermal immunization and by systemic transfer of tumor immunityH T Wepsic, B S Kronman, B Zbar, et al.
The Journal of Urology|December 1, 1995
Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implicationsM M Walther, I A Lubensky, D Venzon, et al.
Pageof 27